[HTML][HTML] Circulating MicroRNAs, the next-generation serum biomarkers in testicular germ cell tumours: a systematic review

R Leao, M Albersen, LHJ Looijenga, T Tandstad… - European urology, 2021 - Elsevier
Context Clinical management of testicular germ cell tumours (GCTs) is hampered by low
sensitivity and specificity of the biomarkers currently in use. Circulating microRNAs (miRs) …

Versatile role of curcumin and its derivatives in lung cancer therapy

M Ashrafizadeh, M Najafi, P Makvandi… - Journal of cellular …, 2020 - Wiley Online Library
Lung cancer is a main cause of death all over the world with a high incidence rate.
Metastasis into neighboring and distant tissues as well as resistance of cancer cells to …

Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours

K Almstrup, J Lobo, N Mørup, G Belge… - Nature Reviews …, 2020 - nature.com
Testicular germ cell tumours (TGCTs) are the most frequent cancer type in young men and
originate from the common precursor germ cell neoplasia in situ (GCNIS). For decades …

Identification and validation model for informative liquid biopsy-based microRNA biomarkers: insights from germ cell tumor in vitro, in vivo and patient-derived data

J Lobo, AJM Gillis, A van den Berg, LCJ Dorssers… - Cells, 2019 - mdpi.com
Liquid biopsy-based biomarkers, such as microRNAs, represent valuable tools for patient
management, but often do not make it to integration in the clinic. We aim to explore issues …

Utility of serum miR-371a-3p in predicting relapse on surveillance in patients with clinical stage I testicular germ cell cancer

J Lobo, R Leao, AJM Gillis, A van den Berg… - European Urology …, 2021 - Elsevier
Background Optimal management of clinical stage I (CSI) testicular cancer is controversial
due to lack of robust prognostic factors; miRNA-371a-3p holds promise as a biomarker …

Refining the serum miR-371a-3p test for viable germ cell tumor detection

JT Lafin, CG Scarpini, A Amini, B Konneh… - Scientific reports, 2023 - nature.com
Abstract Circulating miR-371a-3p has excellent performance in the detection of viable (non-
teratoma) germ cell tumor (GCT) pre-orchiectomy; however, its ability to detect occult …

Integrated expression of circulating miR375 and miR371 to identify teratoma and active germ cell malignancy components in malignant germ cell tumors

L Nappi, M Thi, N Adra, RJ Hamilton, R Leao… - European Urology, 2021 - Elsevier
Active germ cell malignancies express high levels of specific circulating micro-RNAs
(miRNAs), including miR-371a-3p (miR371), which is undetectable in teratoma. Teratoma …

Real-world application of pre-orchiectomy miR-371a-3p test in testicular germ cell tumor management

RR Badia, D Abe, D Wong, N Singla… - The Journal of …, 2021 - auajournals.org
Purpose: Current serum tumor markers for testicular germ cell tumor are limited by low
sensitivity. Growing evidence supports the use of circulating miR-371a-3p as a superior …

Detection of recurrence through microRNA-371a-3p serum levels in a follow-up of stage I testicular germ cell tumors in the DRKS-00019223 study

G Belge, C Dumlupinar, T Nestler, M Klemke… - Clinical Cancer …, 2024 - AACR
Purpose: Surveillance of clinical stage I (CSI) testicular germ cell tumors (GCT) is hampered
by low sensitivity and specificity of current biomarkers for detecting relapses. This study …

[HTML][HTML] Molecular biomarkers with potential clinical application in testicular cancer

J Lobo, AM Acosta, GJ Netto - Modern Pathology, 2023 - Elsevier
Testicular germ cell tumors (TGCTs) and sex cord-stromal tumors (SCSTs) are the most
common testicular neoplasms. The morphological spectrum of such tumors is wide, with …